









Mercados
/
Ações
/
nasdaq-atrc
/

AtriCure Inc

ATRC

35.935USD

+1.525+4.43%

Horário de mercado （ET）Cotações atrasadas em 15 min

1.79BValor de mercado

PerdaP/L TTM



AtriCure Inc

35.935

+1.525+4.43%

Visão Geral Empresa Serviços Financeiros

AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.

Informações da empresa

Código da empresaATRC

Nome da EmpresaAtriCure Inc

Data de listagemAug 05, 2005

CEOMr. Michael H. (Mike) Carrel, CPA

Número de funcionários1300

Tipo de títulosOrdinary Share

Fim do ano fiscalAug 05

Endereço7555 Innovation Way

CidadeMASON

Bolsa de valoresNASDAQ Global Market Consolidated

PaísUnited States of America

Código postal45040

Telefone15137554100

Sitehttps://www.atricure.com

Código da empresaATRC

Data de listagemAug 05, 2005

CEOMr. Michael H. (Mike) Carrel, CPA

Executivos da empresa

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Michael H. (Mike) Carrel, CPA

President, Chief Executive Officer, Director

718.94K

+0.11%

Mr. Salvatore Privitera, J.D.

Chief Technical Officer

125.59K

+0.66%

Mr. Robert S. (Bob) White

Independent Chairman of the Board

92.17K

+20.06%

Mr. Justin J. Noznesky

Chief Marketing and Strategy Officer

86.96K

+23.01%

Dr. Vinayak Doraiswamy, Ph.D.

Chief Scientific Officer

74.37K

+1.12%

Mr. Karl S. Dahlquist, J.D.

Chief Legal Officer

68.55K

+1.21%

Ms. Regina E. (Reggie) Groves

Independent Director

36.17K

+17.56%

Mr. Sven A. Wehrwein, CPA

Independent Director

34.37K

+18.64%

Ms. Deborah H. (Deb) Telman

Independent Director

22.18K

+32.18%

Mr. Shlomo Nachman

Independent Director

18.51K

+41.20%

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Michael H. (Mike) Carrel, CPA

President, Chief Executive Officer, Director

718.94K

+0.11%

Mr. Salvatore Privitera, J.D.

Chief Technical Officer

125.59K

+0.66%

Mr. Robert S. (Bob) White

Independent Chairman of the Board

92.17K

+20.06%

Mr. Justin J. Noznesky

Chief Marketing and Strategy Officer

86.96K

+23.01%

Dr. Vinayak Doraiswamy, Ph.D.

Chief Scientific Officer

74.37K

+1.12%

Mr. Karl S. Dahlquist, J.D.

Chief Legal Officer

68.55K

+1.21%

Detalhamento da receita

Moeda: USDAtualizado em: dom, 6 de jul

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Por EmpresaUSD

Nome

Receita

Proporção

Appendage Management-United states

42.09M

34.05%

Open Ablation - United states

33.31M

26.94%

Pain management

17.27M

13.97%

Appendage management -International

9.67M

7.83%

Open ablation -International

8.99M

7.28%

Other

12.28M

9.94%

Por RegiãoUSD

Nome

Receita

Proporção

United States

101.15M

81.82%

Europe

14.20M

11.49%

Asia

6.78M

5.49%

Other international

1.49M

1.20%

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

Appendage Management-United states

42.09M

34.05%

Open Ablation - United states

33.31M

26.94%

Pain management

17.27M

13.97%

Appendage management -International

9.67M

7.83%

Open ablation -International

8.99M

7.28%

Other

12.28M

9.94%

Distribuição de ações

Atualizado em: ter, 20 de mai

Investidores

Tipos de investidores

Investidores

Proporção

The Vanguard Group, Inc.

9.46%

AllianceBernstein L.P.

7.40%

BlackRock Institutional Trust Company, N.A.

7.19%

Hood River Capital Management LLC

6.03%

Macquarie Investment Management

4.90%

Other

65.02%

Investidores

Proporção

The Vanguard Group, Inc.

9.46%

AllianceBernstein L.P.

7.40%

BlackRock Institutional Trust Company, N.A.

7.19%

Hood River Capital Management LLC

6.03%

Macquarie Investment Management

4.90%

Other

65.02%

Tipos de investidores

Investidores

Proporção

Investment Advisor

56.65%

Investment Advisor/Hedge Fund

33.71%

Hedge Fund

10.66%

Individual Investor

3.55%

Research Firm

1.93%

Pension Fund

0.75%

Bank and Trust

0.50%

Sovereign Wealth Fund

0.23%

Family Office

0.07%

Participação acionária institucional

Atualizado em: ter, 1 de jul

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q2

531

53.52M

108.11%

-4.10M

2025Q1

544

53.44M

107.95%

-4.07M

2024Q4

526

50.00M

102.31%

-11.07M

2024Q3

522

53.78M

110.47%

-8.64M

2024Q2

511

54.11M

111.85%

-4.03M

2024Q1

517

53.02M

109.65%

-1.47M

2023Q4

515

50.20M

105.93%

-1.70M

2023Q3

504

48.87M

103.22%

-3.82M

2023Q2

499

48.88M

103.48%

-3.46M

2023Q1

503

48.62M

102.63%

-1.48M

Ver Mais

Atividade dos acionistas

Nome

Ações detidas

Proporção

Variação

Var. %

Data

The Vanguard Group, Inc.

4.70M

9.5%

+61.17K

+1.32%

Mar 31, 2025

AllianceBernstein L.P.

3.68M

7.43%

-158.60K

-4.14%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

3.57M

7.21%

-92.41K

-2.52%

Mar 31, 2025

Hood River Capital Management LLC

3.00M

6.06%

+75.48K

+2.58%

Mar 31, 2025

Macquarie Investment Management

2.44M

4.92%

+61.60K

+2.59%

Mar 31, 2025

Champlain Investment Partners, LLC

2.14M

4.32%

-390.65K

-15.45%

Mar 31, 2025

Two Sigma Investments, LP

1.33M

2.68%

+75.83K

+6.06%

Mar 31, 2025

First Light Asset Management, LLC

1.31M

2.66%

-654.50K

-33.24%

Mar 31, 2025

State Street Global Advisors (US)

1.28M

2.58%

-68.53K

-5.09%

Mar 31, 2025

UBS Asset Management (Switzerland)

1.26M

2.54%

+537.08K

+74.31%

Mar 31, 2025

Ver Mais

ETFs Relacionados

Atualizado em: sáb, 2 de ago

Nome

Proporção

SPDR S&P Health Care Equipment ETF

1.81%

Harbor Human Capital Factor US Small Cap ETF

0.76%

NYLI Healthy Hearts ETF

0.47%

First Trust Small Cap Growth AlphaDEX Fund

0.45%

Invesco NASDAQ Future Gen 200 ETF

0.43%

Amplify Etho Climate Leadership U.S. ETF

0.3%

JPMorgan Fundamental Data Science Small Core ETF

0.26%

Franklin US Small Cap Multifactor Index ETF

0.25%

First Trust Small Cap Core Alphadex Fund

0.24%

iShares U.S. Medical Devices ETF

0.18%

Ver Mais

SPDR S&P Health Care Equipment ETF

Proporção1.81%

Harbor Human Capital Factor US Small Cap ETF

Proporção0.76%

NYLI Healthy Hearts ETF

Proporção0.47%

First Trust Small Cap Growth AlphaDEX Fund

Proporção0.45%

Invesco NASDAQ Future Gen 200 ETF

Proporção0.43%

Amplify Etho Climate Leadership U.S. ETF

Proporção0.3%

JPMorgan Fundamental Data Science Small Core ETF

Proporção0.26%

Franklin US Small Cap Multifactor Index ETF

Proporção0.25%

First Trust Small Cap Core Alphadex Fund

Proporção0.24%

iShares U.S. Medical Devices ETF

Proporção0.18%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Sem dados

Desdobramento de ações

Data

Tipo

Proporção

Sem dados

Data

Tipo

Proporção

Sem dados

KeyAI

